BRIEF published on 07/24/2024 at 12:35, 1 year 10 months ago Palvella Therapeutics and Pieris Pharmaceuticals Announce Definitive Merger Agreement Merger Financing Nasdaq Biopharmaceutical QTORIN™
PRESS RELEASE published on 07/24/2024 at 12:30, 1 year 10 months ago Palvella Therapeutics and Pieris Pharmaceuticals Announce Definitive Merger Agreement Palvella Therapeutics, Inc. and Pieris Pharmaceuticals, Inc. announce a merger to focus on rare genetic skin diseases with QTORIN™ rapamycin. Joint webcast on July 24 at 8:30am ET Merger Clinical-stage Genetic Skin Diseases QTORIN™ Rapamycin FDA-approved Therapies
BRIEF published on 04/19/2024 at 18:15, 2 years 1 month ago Pieris Pharmaceuticals Announces 1-for-80 Reverse Stock Split Reverse Stock Split Nasdaq Compliance Financial Regulation Pieris Pharmaceuticals Stock Adjustment
PRESS RELEASE published on 04/19/2024 at 18:10, 2 years 1 month ago Pieris Pharmaceuticals Announces 1-for-80 Reverse Stock Split Pieris Pharmaceuticals, Inc. announces a 1-for-80 reverse stock split effective on April 22, 2024, to comply with Nasdaq listing requirements. No fractional shares will be issued Reverse Stock Split Compliance Nasdaq Pieris Pharmaceuticals Stockholder Ownership
BRIEF published on 03/27/2024 at 13:05, 2 years 1 month ago Pieris Pharmaceuticals Announces New Strategy to Maximize Financial Potential Shareholder Value Pieris Pharmaceuticals Strategic Reorganization Milestone Payments Royalty Potential
PRESS RELEASE published on 03/27/2024 at 13:00, 2 years 1 month ago Pieris Pharmaceuticals Announces Strategy to Maximize Partnered Milestone and Royalty Potential Pieris Pharmaceuticals, Inc. announces strategic repositioning to maximize milestone and royalty potential from immuno-oncology assets. Cost-saving measures extend cash runway into 2027 Strategic Repositioning Cost-saving Measures Pieris Pharmaceuticals Milestone Payments Immuno-oncology Assets
Published on 05/27/2026 at 02:10, 6 hours 30 minutes ago Western Investment Company Reports First Quarter 2026 Results and Announces Executive Personnel Changes
Published on 05/27/2026 at 01:45, 6 hours 55 minutes ago Organto Foods Announces Record First Quarter 2026 Financial Results
Published on 05/27/2026 at 00:25, 8 hours 15 minutes ago Revolve Reports Q3 F2026 Results Backed by Strong Progress Across North American Portfolio
Published on 05/26/2026 at 22:15, 10 hours 25 minutes ago LaFleur Announces Bought Deal Equity Offerings for Gross Proceeds of C$8 Million
Published on 05/26/2026 at 22:01, 10 hours 39 minutes ago Kidoz Inc. Reports Q1 2026 Financial Results with YoY Revenue Growth, Accelerating Strategic Investment in AI
Published on 05/27/2026 at 08:30, 10 minutes ago MPH Health Care AG publishes Annual Report 2025 The Executive Board and Supervisory Board will propose an increased dividend of €5.00 per share to the Annual General Meeting on 9 July 2026
Published on 05/27/2026 at 08:22, 17 minutes ago Corporate News: Statement from KTM AG regarding current media reports on Enduro Models
Published on 05/27/2026 at 07:30, 1 hour 10 minutes ago Aroundtown announces Q1 2026 results in line with guidance. Earnings profile reinforced by successful GCP share-to-share offer and effective capital recycling
Published on 05/27/2026 at 07:30, 1 hour 10 minutes ago CONSOLIDATED AUDITED FINANCIAL RESULTS FOR THE YEAR ENDED 31 MARCH 2026 AND PROPOSED DIVIDEND
Published on 05/26/2026 at 18:39, 14 hours ago Reporting on share buyback transactions carried out on May 18, 2026
Published on 05/26/2026 at 17:45, 14 hours 55 minutes ago EURAZEO INVESTS IN BABYLON, A FRENCH OPERATOR OF NEXT-GENERATION APARTHOTELS
Published on 05/26/2026 at 15:00, 17 hours 40 minutes ago Resolutions Ordinary and Extraordinary General Meetings
Published on 05/26/2026 at 07:59, 1 day ago Saint-Gobain has signed an agreement for the sale of its Tiles Distribution business in the Nordics
